Literature DB >> 16542746

Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.

Hong Kee Kim1, Hyun Jung Chung, Tae Gwan Park.   

Abstract

A new approach for attaining sustained release of protein is introduced, involving a pore-closing process of preformed porous PLGA microspheres. Highly porous biodegradable poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres were fabricated by a single water-in-oil emulsion solvent evaporation technique using Pluronic F127 as an extractable porogen. Recombinant human growth hormone (rhGH) was incorporated into porous microspheres by a simple solution dipping method. For their controlled release, porous microspheres containing hGH were treated with water-miscible solvents in aqueous phase for production of pore-closed microspheres. These microspheres showed sustained release patterns over an extended period; however, the drug loading efficiency was extremely low. To overcome the drug loading problem, the pore-closing process was performed in an ethanol vapor phase using a fluidized bed reactor. The resultant pore-closed microspheres exhibited high protein loading amount as well as sustained rhGH release profiles. Also, the released rhGH exhibited structural integrity after the treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542746     DOI: 10.1016/j.jconrel.2006.02.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  33 in total

1.  Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.

Authors:  Adam Bohr; Jakob Kristensen; Mark Dyas; Mohan Edirisinghe; Eleanor Stride
Journal:  J R Soc Interface       Date:  2012-04-25       Impact factor: 4.118

2.  Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics.

Authors:  Adam Bohr; Feng Wan; Jakob Kristensen; Mark Dyas; Eleanor Stride; Stefania Baldursdottír; Mohan Edirisinghe; Mingshi Yang
Journal:  J Mater Sci Mater Med       Date:  2015-01-29       Impact factor: 3.896

Review 3.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

4.  Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion.

Authors:  Drew L Sellers; Tae Hee Kim; Christopher W Mount; Suzie H Pun; Philip J Horner
Journal:  Biomaterials       Date:  2014-07-23       Impact factor: 12.479

Review 5.  Injectable controlled release depots for large molecules.

Authors:  Steven P Schwendeman; Ronak B Shah; Brittany A Bailey; Anna S Schwendeman
Journal:  J Control Release       Date:  2014-06-12       Impact factor: 9.776

6.  Novel antibacterial nanofibrous PLLA scaffolds.

Authors:  Kai Feng; Hongli Sun; Mark A Bradley; Ellen J Dupler; William V Giannobile; Peter X Ma
Journal:  J Control Release       Date:  2010-06-04       Impact factor: 9.776

7.  Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.

Authors:  Hyun Jung Chung; Hong Kee Kim; Jun Jin Yoon; Tae Gwan Park
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

8.  Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process.

Authors:  Ai-Zheng Chen; Yue-Mei Yang; Shi-Bin Wang; Guang-Ya Wang; Yuan-Gang Liu; Qing-Qing Sun
Journal:  J Mater Sci Mater Med       Date:  2013-05-10       Impact factor: 3.896

Review 9.  Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery.

Authors:  Sachin Gharse; Jennifer Fiegel
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.

Authors:  Bradley S Miller; Eric Velazquez; Kevin C J Yuen
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.